Search Results - "Higuera Gómez, O."

Cognitive functions, coping strategies and psychological distress in patients with resected non-advanced cancer receiving chemotherapy: NEOcoping study data by Higuera Gomez, O., Calderón, C., Ghanem, I., Carmona-Bayonas, A., Jara, C., Hernández, R., Castelo, B., Muñoz, M.M., Beato, C., García, S., Martínez, E., Mut, M., Ramchandani Vaswani, A., Mangas, M., Donnay, O., García-García, M.T., Soriano, M.C., Carrión, R., Iglesias Gomez, C., Jimenez Fonseca, P.

Get full text

1868P Efficacy and safety of naloxegol in patients with cancer with opioid-induced constipation with laxative-inadequate response: A long-term, real-world study by Beato Zambrano, C., Cobo Dols, M., Cabezón Gutiérrez, L., Chicas-Sett, R., Blancas López-Barajas, M.I., García-Navalón, F.J., Firvida Pérez, J.L., Llorens Torromé, S., Togores Torres, P., Delgado Mingorance, I., Giraldo Marín, A., Librán Oriol, A., Paredes Lario, A., Sánchez Mauriño, P., Higuera Gómez, O., Moreno Muñoz, D., Huerta González, I., Sanz Yagüe, A., Soler López, B.

Get full text

"High Tumor Burden" in Metastatic Non-Small Cell Lung Cancer: Defining the Concept by Higuera Gómez, Oliver, Moreno Paul, Amaia, Ortega Granados, Ana Laura, Ros Martínez, Silverio, Pérez Parente, Diego, Ruiz Gracia, Pedro, Sáenz Cuervo-Arango, Lucía, Vilà, Laia

“…Identifying patient characteristics that define a worse disease prognosis or "high tumor burden" (HTB) status is essential for clinical decision-making and…”
Get full text

Estudio observacional, prospectivo y multicéntrico sobre el uso de citrato de fentanilo transmucosa en la práctica clínica habitual para el control de las crisis de dolor irruptivo en pacientes oncológicos by Folgueira Hernández, Brozos Vázquez, EM, Cámara Vicario, JC, Olay Gayoso, González Gragera, MB, Higuera Gómez, Ramírez Daffos, Arasanz Esteban

“…RESUMEN Objetivo: Evaluar el grado de satisfacción de los pacientes y/o cuidadores con el tratamiento de citrato de fentanilo transmucosa en la gestión de las…”
Get full text

1737P Use of the predictive risk model LungFlagTM for lung cancer screening in screening in a Spanish reference center: A cost-effectiveness analysis by Olmedo Garcia, M.E., Gorospe, L., Seijo Maceiras, L.M., Pajares, V., Marzo Castillejo, M., Soriano, J.B., Trujillo, J.C., Arrabal, N., Flores, A., Garcia Verdes-Montenegro, F., Crespo, M., Carcedo, D., Heuser, C., Olghi, N., Choman, E.N., Higuera Gomez, O.

Get full text

2123P Value of immuno-nutritional scores in the prognosis of hospitalised patients with lung cancer by López, J.P., Bou, D. Jiménez, Ruiz-Gutiérrez, I., Sainz, L. Gutierrez, Navas-Jiménez, C., Alonso-Eiras, J.I., García-Zamarriego, Á., Cabrero, D. Sanchez, Jimenez Ubeda, L. Ruiz, Pertejo, A., Wert, J.P. Perez, Alonso-Babarro, A., Castellanos, P. Cruz, Gomez, O. Higuera, de Castro Carpeño, J.

Get full text

24P Preliminary data on INHERITY LC: Germline mutations of a cohort of selected non-small cell lung cancer (NSCLC) patients by Zurera, M., Lastra, R., Mezquita, L., Higuera Gomez, O., De Castro Carpeno, J., Corral Jaime, J., Garrido Lopez, P., Felip, E., Majem Tarruella, M., Marquez Medina, D., Menao, S., Ortega Granados, A.L.O., Remon Masip, J., Vinolas Segarra, N., Arruebo, M., Isla, D.

Get full text

474P Prognostic and predictive role of Consensus Molecular Subtypes (CMS) determined by immunohistochemistry in metastatic colorectal cancer (mCRC) by Gomez, O. Higuera, Soto, V. Heredia, Machado, I., Mendez, M.C., Cuatrecasas, M., Horndler, C., Vermeulen, L., Hoorn, S. Ten, Mendiola, M., Martín-Richard, M., Ruiz-Casado, A., Galvez, E., Aparicio, J., García, I. Sevilla, Leno, R., Fernández-Martos, C., Alonso-Orduna, V., Montes, A. Fernandez, Maurel, J., Feliu, J.

Get full text

Incidence of vascular thromboembolism events in cancer patients receiving immunotherapy: A single institution experience by Gutiérrez Sainz, L., Martínez-Marin, V., Viñal Lozano, D., Martínez Pérez, D., Pedregosa Barbas, J., García Cuesta, J.A., Villamayor Sánchez, J., Zamora, P., Pinto Marin, A., Castelo, B., Redondo, A., Gallego Martínez, A., Cruz, P., Higuera Gomez, O., Custodio, A., Sánchez Cabrero, D., De Castro Carpeno, J., Espinosa, E., Feliu Batlle, J.

Get full text

1821P - Analysis of the efficacy of naloxegol in a real-world 12 weeks of follow-up study, in patients with cancer and opioid-induced constipation with laxative-inadequate response by Cobo Dols, M., Beato Zambrano, M.D.C., Cabezón Gutiérrez, L., Chicas Sett, R., Blancas, I., García Navalón, F.J., Firvida Pérez, J.L., Serrano Bermúdez, G., Togores Torres, P., Delgado Mingorance, I., Giraldo Marín, A., Librán Oriol, A., Paredes Lario, A., Sánchez Mauriño, P., Higuera Gomez, O., Moreno Muñoz, D., Jiménez López, A.J., Huerta González, I., Sanz Yagüe, A., Soler López, B.

“…Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main objective of this study was to…”
Get full text

Analysis of the efficacy of naloxegol in a real-world 12 weeks of follow-up study, in patients with cancer and opioid-induced constipation with laxative-inadequate response by Cobo Dols, M., Beato Zambrano, M.D.C., Cabezón Gutiérrez, L., Chicas Sett, R., Blancas, I., García Navalón, F.J., Firvida Pérez, J.L., Serrano Bermúdez, G., Togores Torres, P., Delgado Mingorance, I., Giraldo Marín, A., Librán Oriol, A., Paredes Lario, A., Sánchez Mauriño, P., Higuera Gomez, O., Moreno Muñoz, D., Jiménez López, A.J., Huerta González, I., Sanz Yagüe, A., Soler López, B.

Get full text

1821PAnalysis of the efficacy of naloxegol in a real-world 12 weeks of follow-up study, in patients with cancer and opioid-induced constipation with laxative-inadequate response by Cobo Dols, M, Beato Zambrano, M D C, Cabezón Gutiérrez, L, Chicas Sett, R, Blancas, I, García Navalón, F J, Firvida Pérez, J L, Serrano Bermúdez, G, Togores Torres, P, Delgado Mingorance, I, Giraldo Marín, A, Librán Oriol, A, Paredes Lario, A, Sánchez Mauriño, P, Higuera Gomez, O, Moreno Muñoz, D, Jiménez López, A J, Huerta González, I, Sanz Yagüe, A, Soler López, B

“…Abstract Background Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main objective of…”
Get full text

1775PIncidence of vascular thromboembolism events in cancer patients receiving immunotherapy: A single institution experience by Gutiérrez Sainz, L, Martínez-Marin, V, Viñal Lozano, D, Martínez Pérez, D, Pedregosa Barbas, J, García Cuesta, J A, Villamayor Sánchez, J, Zamora, P, Pinto Marin, A, Castelo, B, Redondo, A, Gallego Martínez, A, Cruz, P, Higuera Gomez, O, Custodio, A, Sánchez Cabrero, D, De Castro Carpeno, J, Espinosa, E, Feliu Batlle, J

“…Abstract Background Cancer and cancer therapy, such as chemotherapy and vascular endothelial growth factor targeted therapies, have been associated with an…”
Get full text

1775P - Incidence of vascular thromboembolism events in cancer patients receiving immunotherapy: A single institution experience by Gutiérrez Sainz, L., Martínez-Marin, V., Viñal Lozano, D., Martínez Pérez, D., Pedregosa Barbas, J., García Cuesta, J.A., Villamayor Sánchez, J., Zamora, P., Pinto Marin, A., Castelo, B., Redondo, A., Gallego Martínez, A., Cruz, P., Higuera Gomez, O., Custodio, A., Sánchez Cabrero, D., De Castro Carpeno, J., Espinosa, E., Feliu Batlle, J.

“…Cancer and cancer therapy, such as chemotherapy and vascular endothelial growth factor targeted therapies, have been associated with an increased incidence of…”
Get full text

1544PCognitive functions, coping strategies and psychological distress in patients with resected non-advanced cancer receiving chemotherapy: NEOcoping study data by Higuera Gomez, O, Calderón, C, Ghanem, I, Carmona-Bayonas, A, Jara, C, Hernández, R, Castelo, B, Muñoz, M M, Beato, C, García, S, Martínez, E, Mut, M, Ramchandani Vaswani, A, Mangas, M, Donnay, O, García-García, M T, Soriano, M C, Carrión, R, Iglesias Gomez, C, Jimenez Fonseca, P

Get full text

178P Germline testing in non-small cell lung cancer (NSCLC): Real-world impact of the discovery of germline pathogenic variants (PGV) in the INHERITY LC (ILC) study by Montes, J.C. Laguna, Lastra, R., Gomez, O. Higuera, Berjaga, M. Zurera, Pellitero, A. Moratiel, Menao-Guillen, S., Arruebo, M., Potrony, M., Sole, X., Arcocha, A., Moreno, L., Sainz, L. Gutierrez, Teixido, C., Segarra, N. Vinolas, De-Castro, J., Casado, M.D. Isla, Mezquita, L.

Get full text